RARPKB

Groups information

Group name

Focal treatment (Total)

Groups definition

patients underwent sRARP after focal or whole-gland primary treatment

Baseline information

Age

67

Age remark

Median (IQR) (yrs)

BMI

27.8

PSA

5.2

American Society of Aneshesiologists (ASA) physical status classification

average ASA

2

Charlson comorbidity index (CCI)

Risk classification

low

2(3)

intermediate

32 (52)

high

27 (44)

Risk remark

D'Amico risk class